This Order revokes the Equality Act 2010 Code of Practice on Services, Public Functions and Associations that has been in effect since 6 April 2011.

It acts on a formal request from the Commission for Equality and Human Rights to the Secretary of State, clearing the legal path for an updated 2026 Code of Practice to take effect.

The revocation applies across England, Wales, and Scotland, affecting how service providers, public bodies, and associations interpret their duties under the Equality Act 2010.

These Regulations extend the statutory time limits for bringing various employment-related claims before an Employment Tribunal from three months to six months.

The instrument amends specific regulations concerning part-time workers, fixed-term employees, information and consultation rights, blacklisting protection, zero-hours contract exclusivity, and whistleblowing protections in NHS recruitment.

These changes apply to specific acts, failures to act, or the last in a series of such events occurring on or after 1 October 2026 in England, Wales, and Scotland.

These regulations amend the National Health Service (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 to include several additional vaccines in the list of medicines eligible for zero or nominal reimbursement.

They apply to NHS pharmaceutical service providers in England who administer centrally purchased vaccines for meningococcal disease (groups A, C, W, Y, and B), tetanus, diphtheria, and polio.

The instrument ensures that where the government has already paid for the supply of these vaccines, pharmacies do not receive a standard purchase price reimbursement for them.

These Regulations establish the statutory purity criteria for magnesium L-threonate monohydrate when used as a mineral source in food supplements.

The Secretary of State for Health and Social Care mandates that this substance must meet specific chemical identities, assay percentages for magnesium and L-threonate, and maximum limits for impurities like arsenic, lead, and oxalic acid.

These requirements apply to any person or business producing or marketing this substance for food supplement use within England.

This correction slip amends a typographical error found in the National Health Service (Primary Dental Services and Dental Charges) (Amendment) (No. 2) Regulations 2026.

It specifically instructs that the reference to '17A(7)(d)(ii)' in regulation 13(2)(b) be replaced with '13A(7)(d)(ii)'.

The document applies to the published text of the regulations and ensures the statutory references align with the intended legislative structure for primary dental services in England.

This document issues a formal clerical correction to the Housing Health and Safety Rating System (England) (Amendment) Regulations 2026.

It directs that the opening text of regulation 1 be designated as paragraph (1) and requires the re-designation of existing paragraphs (1) and (2) as paragraphs (2) and (3) respectively.

These changes apply to the published version of the statutory instrument under the authority of the Controller of His Majesty’s Stationery Office.

These Regulations amend the transitional provisions related to housing health and safety inspections in England by changing a reference date.

They ensure that the transitional rules for how dwellings are assessed by local housing authorities align with the commencement date of June 23, 2026.

The instrument applies to the Secretary of State and local authorities responsible for enforcing housing standards under the Housing Act 2004.

These Regulations, made by the Secretary of State for Health and Social Care, amend the Branded Health Service Medicines (Costs) Regulations 2018, which establishes a scheme requiring manufacturers and suppliers of branded medicines for the National Health Service (NHS) to pay amounts based on net sales income; the amendments update specific payment percentages applicable for periods beginning July 1st, 2026, and for subsequent years across England, Wales, Scotland, and Northern Ireland.